Cleared Traditional

K994409 - INSTANT-VIEW OPIATES/MORPHINE URINE DIP STRIP TEST

K994409 is an FDA 510(k) clearance for INSTANT-VIEW OPIATES/MORPHINE URINE DIP..., manufactured by Alfa Scientific Designs, Inc.. The device is a Class 2 Toxicology device with product code DPK cleared through the Traditional 510(k) pathway after a 195-day FDA review.

K994409 · Alfa Scientific Designs, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2000
Decision
195d
Days
Class 2
Risk

K994409 is an FDA 510(k) clearance for the INSTANT-VIEW OPIATES/MORPHINE URINE DIP STRIP TEST. Classified as Liquid Chromatography, Morphine (product code DPK), Class II - Special Controls.

Submitted by Alfa Scientific Designs, Inc. (San Diego, US). The FDA issued a Cleared decision on July 10, 2000 after a review of 195 days - an extended review cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3640 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.

View all Alfa Scientific Designs, Inc. devices

FDA 510(k) Submission Details - K994409

510(k) Number K994409 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 28, 1999
Decision Date July 10, 2000
Days to Decision 195 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
108d slower than avg
Panel avg: 87d · This submission: 195d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPK Device Classification - Class 2, Special Controls

Product Code DPK Liquid Chromatography, Morphine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.